Twinbeech Capital LP Legend Biotech Corp Transaction History

Twinbeech Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $168,153 - $213,749	3,054 Added 8.21%	40,239 $2.26 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $2.13 Million - $2.59 Million	37,185 New	37,185 $2.24 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $931,523 - $1.51 Million	20,128 New	20,128 $1.39 Million
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $619,752 - $885,862	15,973 New	15,973 $797,000
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $248,532 - $386,018	-8,012 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $329,613 - $456,523	8,012 New	8,012 $373,000

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.